UBS Group’s Adial Pharmaceuticals ADIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$970 Buy
542
+175
+48% +$615 ﹤0.01% 9673
2025
Q4
$2.02K Sell
367
-383
-51% -$3.1K ﹤0.01% 9404
2025
Q3
$6.62K Buy
750
+254
+51% +$2.48K ﹤0.01% 8772
2025
Q2
$3.74K Sell
496
-1,414
-74% -$21.4K ﹤0.01% 9324
2025
Q1
$30.3K Buy
1,910
+1,069
+127% +$22.1K ﹤0.01% 7937
2024
Q4
$21.2K Buy
841
+665
+378% +$17.3K ﹤0.01% 7829
2024
Q3
$4.4K Sell
176
-3,168
-95% -$82.6K ﹤0.01% 8146
2024
Q2
$96.1K Buy
3,344
+3,115
+1,360% +$118K ﹤0.01% 6184
2024
Q1
$7.62K Buy
229
+84
+58% +$3.14K ﹤0.01% 7375
2023
Q4
$6.74K Buy
145
+123
+559% +$6.74K ﹤0.01% 7675
2023
Q3
$1.52K Buy
+22
New +$2.6K ﹤0.01% 7913
2023
Q2
Sell
-17
Closed -$3.72K 8825
2023
Q1
$3.72K Sell
17
-18
-51% -$4.36K ﹤0.01% 8284
2022
Q4
$4.85K Sell
35
-22
-39% -$3.85K ﹤0.01% 9268
2022
Q3
$12K Buy
+57
New +$25.7K ﹤0.01% 8136
2022
Q2
Sell
-11
Closed -$14K 10241
2022
Q1
$14K Buy
11
+5
+83% +$6.85K ﹤0.01% 7916
2021
Q4
$10K Sell
6
-1
-14% -$1.97K ﹤0.01% 8754
2021
Q3
$19K Buy
+7
New +$14.7K ﹤0.01% 7194
2021
Q2
Sell
-7
Closed -$11K 9338
2021
Q1
$11K Sell
7
-11
-61% -$16.6K ﹤0.01% 7843
2020
Q4
$19K Buy
18
+16
+800% +$18.9K ﹤0.01% 6975
2020
Q3
$3K Buy
+2
New +$1.86K ﹤0.01% 7504
2019
Q3
Sell
-3
Closed -$3K 7950
2019
Q2
$3K Sell
3
-3
-50% -$4.47K ﹤0.01% 7515
2019
Q1
$13K Buy
6
+2
+50% +$5.96K ﹤0.01% 6626
2018
Q4
$14K Buy
4
+3
+300% +$4.79K ﹤0.01% 7023
2018
Q3
$2K Buy
+1
New +$2.08K ﹤0.01% 7722

Other funds holding ADIL